Now showing items 1-4 of 4

    • Glycyrrhetinic acid derivatives 

      Safe, Stephen H.; Chintharlapalli, Sudhakar; Mcalees, Alan; Mccrindle, Robert (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2013-03-05)
      The present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr ...
    • Implantable system for glucose monitoring using fluorescence quenching 

      Ibey, Bennett L.; Yadavalli, Vamsi K.; Rounds, Rebecca M.; Beier, Hope T.; Cote, Gerard L.; Pishko, Michael V. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2010-04-27)
      This disclosure relates to systems, devices, and methods of sensing an analyte. An implantable sensor may be contacted with a test sample under conditions that permit a binding protein and a ligand of the sensor to interact ...
    • Method for glucose monitoring using fluorescence quenching 

      Ibey, Bennett L.; Yadavalli, Vamsi K.; Rounds, Rebecca M.; Beier, Hope T.; Cote, Gerard L.; Pishko, Michael V. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2012-01-03)
      This disclosure relates to a method of measuring a glucose concentration metric or a glucose metric in a patient by contacting an implantable glucose-sensing device with a test sample, which may be in the patient, under ...
    • Method of treating endothelial dysfunction comprising administration of a thrombin peptide derivative 

      Carney, Darrell H.; Olszewska-pazdrak, Barbara; Fossum, Theresa W. (United States. Patent and Trademark OfficeTexas A&M University. Libraries, 2012-12-18)
      Endothelial dysfunction (ED) is associated with a number of diseases and disorders. Agonists of the non-proteolytically activated thrombin receptor can be used in methods to treat ED or ED-related diseases and disorders.